Generic Industry’s Drug Shortage Program Creates Trigger Mechanism For FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
GPhA enlists IMS Health for analysis of production data to help FDA devise roadmap to ameliorate shortages when a company plans to halt or interrupt a drug’s manufacture.